awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q38798654-092BFAB3-74D6-4FDA-8549-D98E575DC132
Q38798654-092BFAB3-74D6-4FDA-8549-D98E575DC132
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38798654-092BFAB3-74D6-4FDA-8549-D98E575DC132
The effects of canagliflozin, a sodium glucose co-transporter 2 inhibitor, on mineral metabolism and bone in patients with type 2 diabetes mellitus.
P2860
Q38798654-092BFAB3-74D6-4FDA-8549-D98E575DC132
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38798654-092BFAB3-74D6-4FDA-8549-D98E575DC132
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
10938c69adbe8e5aae1a5c41d4ce1d5870dad099
P2860
Efficacy and safety of canagliflozin monotherapy in subjects with type 2 diabetes mellitus inadequately controlled with diet and exercise.